Rational design of peptidomimetics for class B GPCRs: Potent non-peptide GLP-1 receptor agonists

Advances in Experimental Medicine and Biology

Volumn 611, Issue , 2009, Pages 125-126

  Ahn, Jung Mo ^a   Han, Sun Young ^a   Murage, Eunice ^a   Beinborn, Martin ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAMIDE DERIVATIVE; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; PEPTIDOMIMETIC AGENT; GLUCAGON LIKE PEPTIDE RECEPTOR; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE RECEPTOR; PEPTIDE;

ALPHA HELIX; ANIMAL CELL; ARTICLE; COMPUTER ANALYSIS; COMPUTER PROGRAM; DRUG CONFORMATION; DRUG DESIGN; DRUG SYNTHESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RECEPTOR BINDING; SUBSTITUTION REACTION; VALIDATION PROCESS; X RAY CRYSTALLOGRAPHY; CHEMICAL STRUCTURE; CHEMISTRY; DRUG POTENTIATION; MOLECULAR MIMICRY; PROTEIN CONFORMATION;

CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; MODELS, MOLECULAR; MOLECULAR MIMICRY; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES; PROTEIN CONFORMATION; RECEPTORS, GLUCAGON;

EID: 66349084499     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-73657-0_55     Document Type: Article

References (8)

1. George, S. R., et al. Nature Rev. Drug Discovery 1, 808-820 (2002).
2. Hoare, S. R. J. Drug Discovery Today 10, 417-427 (2005).
3. Drucker, D. J. Diabetes Care 26, 2929-2940 (2003).
4. Neer, R. M., et al. N. Engl. J. Med. 344, 1434-1441 (2001).
5. Bale, T. L. and Vale, W. W. Annu. Rev. Pharmacol. Toxicol. 44, 525-557 (2004).
6. Mesleh et al. J. Biol. Chem. 282, 6338-6346 (2007).
7. Thornton, K. and Gorenstein, D. G. Biochemistry 33, 3532-3539 (1994).
8. Tibaduiza, E. C., et al. J. Biol. Chem. 276, 37787-37793 (2001).